nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—Wheezing—Levothyroxine—hypothyroidism	0.022	0.0319	CcSEcCtD
Cyproheptadine—Wheezing—Dextrothyroxine—hypothyroidism	0.022	0.0319	CcSEcCtD
Cyproheptadine—HTR2A—cerebellar cortex—hypothyroidism	0.0211	0.113	CbGeAlD
Cyproheptadine—Increased appetite—Dextrothyroxine—hypothyroidism	0.0175	0.0254	CcSEcCtD
Cyproheptadine—Increased appetite—Levothyroxine—hypothyroidism	0.0175	0.0254	CcSEcCtD
Cyproheptadine—Wheezing—Liotrix—hypothyroidism	0.0162	0.0235	CcSEcCtD
Cyproheptadine—Tachycardia—Liothyronine—hypothyroidism	0.016	0.0233	CcSEcCtD
Cyproheptadine—Irritability—Dextrothyroxine—hypothyroidism	0.0157	0.0228	CcSEcCtD
Cyproheptadine—Irritability—Levothyroxine—hypothyroidism	0.0157	0.0228	CcSEcCtD
Cyproheptadine—Hypotension—Liothyronine—hypothyroidism	0.0153	0.0223	CcSEcCtD
Cyproheptadine—Sweating increased—Levothyroxine—hypothyroidism	0.0138	0.0201	CcSEcCtD
Cyproheptadine—Sweating increased—Dextrothyroxine—hypothyroidism	0.0138	0.0201	CcSEcCtD
Cyproheptadine—SLC6A2—nerve—hypothyroidism	0.0129	0.0691	CbGeAlD
Cyproheptadine—Increased appetite—Liotrix—hypothyroidism	0.0128	0.0187	CcSEcCtD
Cyproheptadine—DRD2—nerve—hypothyroidism	0.0117	0.063	CbGeAlD
Cyproheptadine—Irritability—Liotrix—hypothyroidism	0.0115	0.0168	CcSEcCtD
Cyproheptadine—HTR2A—urine—hypothyroidism	0.0112	0.0602	CbGeAlD
Cyproheptadine—Sweating increased—Liotrix—hypothyroidism	0.0102	0.0148	CcSEcCtD
Cyproheptadine—UGT1A3—liver—hypothyroidism	0.0099	0.0533	CbGeAlD
Cyproheptadine—Tension—Levothyroxine—hypothyroidism	0.0097	0.0141	CcSEcCtD
Cyproheptadine—Tension—Dextrothyroxine—hypothyroidism	0.0097	0.0141	CcSEcCtD
Cyproheptadine—Nervousness—Dextrothyroxine—hypothyroidism	0.0096	0.014	CcSEcCtD
Cyproheptadine—Nervousness—Levothyroxine—hypothyroidism	0.0096	0.014	CcSEcCtD
Cyproheptadine—Tremor—Levothyroxine—hypothyroidism	0.00926	0.0135	CcSEcCtD
Cyproheptadine—Tremor—Dextrothyroxine—hypothyroidism	0.00926	0.0135	CcSEcCtD
Cyproheptadine—Agitation—Dextrothyroxine—hypothyroidism	0.00908	0.0132	CcSEcCtD
Cyproheptadine—Agitation—Levothyroxine—hypothyroidism	0.00908	0.0132	CcSEcCtD
Cyproheptadine—Palpitations—Dextrothyroxine—hypothyroidism	0.00873	0.0127	CcSEcCtD
Cyproheptadine—Palpitations—Levothyroxine—hypothyroidism	0.00873	0.0127	CcSEcCtD
Cyproheptadine—Convulsion—Levothyroxine—hypothyroidism	0.00856	0.0125	CcSEcCtD
Cyproheptadine—Convulsion—Dextrothyroxine—hypothyroidism	0.00856	0.0125	CcSEcCtD
Cyproheptadine—Confusional state—Levothyroxine—hypothyroidism	0.00813	0.0118	CcSEcCtD
Cyproheptadine—Confusional state—Dextrothyroxine—hypothyroidism	0.00813	0.0118	CcSEcCtD
Cyproheptadine—Shock—Levothyroxine—hypothyroidism	0.00794	0.0115	CcSEcCtD
Cyproheptadine—Shock—Dextrothyroxine—hypothyroidism	0.00794	0.0115	CcSEcCtD
Cyproheptadine—Tachycardia—Dextrothyroxine—hypothyroidism	0.00787	0.0114	CcSEcCtD
Cyproheptadine—Tachycardia—Levothyroxine—hypothyroidism	0.00787	0.0114	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.0078	0.0113	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Levothyroxine—hypothyroidism	0.0078	0.0113	CcSEcCtD
Cyproheptadine—HTR2A—nerve—hypothyroidism	0.00773	0.0416	CbGeAlD
Cyproheptadine—Insomnia—Levothyroxine—hypothyroidism	0.0073	0.0106	CcSEcCtD
Cyproheptadine—Insomnia—Dextrothyroxine—hypothyroidism	0.0073	0.0106	CcSEcCtD
Cyproheptadine—Tension—Liotrix—hypothyroidism	0.00713	0.0104	CcSEcCtD
Cyproheptadine—Nervousness—Liotrix—hypothyroidism	0.00706	0.0103	CcSEcCtD
Cyproheptadine—Fatigue—Dextrothyroxine—hypothyroidism	0.00695	0.0101	CcSEcCtD
Cyproheptadine—Fatigue—Levothyroxine—hypothyroidism	0.00695	0.0101	CcSEcCtD
Cyproheptadine—Vision blurred—Liotrix—hypothyroidism	0.00685	0.00996	CcSEcCtD
Cyproheptadine—Tremor—Liotrix—hypothyroidism	0.00681	0.0099	CcSEcCtD
Cyproheptadine—Agitation—Liotrix—hypothyroidism	0.00668	0.00972	CcSEcCtD
Cyproheptadine—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00665	0.00967	CcSEcCtD
Cyproheptadine—Feeling abnormal—Levothyroxine—hypothyroidism	0.00665	0.00967	CcSEcCtD
Cyproheptadine—Syncope—Liotrix—hypothyroidism	0.00652	0.00948	CcSEcCtD
Cyproheptadine—Palpitations—Liotrix—hypothyroidism	0.00642	0.00934	CcSEcCtD
Cyproheptadine—Urticaria—Dextrothyroxine—hypothyroidism	0.00641	0.00932	CcSEcCtD
Cyproheptadine—Urticaria—Levothyroxine—hypothyroidism	0.00641	0.00932	CcSEcCtD
Cyproheptadine—Loss of consciousness—Liotrix—hypothyroidism	0.00639	0.00929	CcSEcCtD
Cyproheptadine—Convulsion—Liotrix—hypothyroidism	0.0063	0.00916	CcSEcCtD
Cyproheptadine—Confusional state—Liotrix—hypothyroidism	0.00598	0.0087	CcSEcCtD
Cyproheptadine—Oedema—Liotrix—hypothyroidism	0.00593	0.00863	CcSEcCtD
Cyproheptadine—CHRM2—heart—hypothyroidism	0.00593	0.0319	CbGeAlD
Cyproheptadine—Shock—Liotrix—hypothyroidism	0.00584	0.00849	CcSEcCtD
Cyproheptadine—Tachycardia—Liotrix—hypothyroidism	0.00579	0.00842	CcSEcCtD
Cyproheptadine—Asthenia—Levothyroxine—hypothyroidism	0.00579	0.00842	CcSEcCtD
Cyproheptadine—Asthenia—Dextrothyroxine—hypothyroidism	0.00579	0.00842	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Liotrix—hypothyroidism	0.00574	0.00834	CcSEcCtD
Cyproheptadine—Anorexia—Liotrix—hypothyroidism	0.00566	0.00822	CcSEcCtD
Cyproheptadine—CHRM2—cardiovascular system—hypothyroidism	0.0056	0.0301	CbGeAlD
Cyproheptadine—HTR2B—adrenal cortex—hypothyroidism	0.00555	0.0299	CbGeAlD
Cyproheptadine—Hypotension—Liotrix—hypothyroidism	0.00554	0.00806	CcSEcCtD
Cyproheptadine—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00552	0.00803	CcSEcCtD
Cyproheptadine—Diarrhoea—Levothyroxine—hypothyroidism	0.00552	0.00803	CcSEcCtD
Cyproheptadine—HTR2B—heart—hypothyroidism	0.00537	0.0289	CbGeAlD
Cyproheptadine—Insomnia—Liotrix—hypothyroidism	0.00537	0.0078	CcSEcCtD
Cyproheptadine—Paraesthesia—Liotrix—hypothyroidism	0.00533	0.00775	CcSEcCtD
Cyproheptadine—Decreased appetite—Liotrix—hypothyroidism	0.00516	0.0075	CcSEcCtD
Cyproheptadine—Vomiting—Dextrothyroxine—hypothyroidism	0.00513	0.00746	CcSEcCtD
Cyproheptadine—Vomiting—Levothyroxine—hypothyroidism	0.00513	0.00746	CcSEcCtD
Cyproheptadine—Fatigue—Liotrix—hypothyroidism	0.00512	0.00744	CcSEcCtD
Cyproheptadine—CHRM1—cardiovascular system—hypothyroidism	0.0051	0.0274	CbGeAlD
Cyproheptadine—Rash—Dextrothyroxine—hypothyroidism	0.00509	0.0074	CcSEcCtD
Cyproheptadine—Rash—Levothyroxine—hypothyroidism	0.00509	0.0074	CcSEcCtD
Cyproheptadine—Dermatitis—Dextrothyroxine—hypothyroidism	0.00508	0.00739	CcSEcCtD
Cyproheptadine—Dermatitis—Levothyroxine—hypothyroidism	0.00508	0.00739	CcSEcCtD
Cyproheptadine—Constipation—Liotrix—hypothyroidism	0.00507	0.00738	CcSEcCtD
Cyproheptadine—HTR2B—cardiovascular system—hypothyroidism	0.00507	0.0273	CbGeAlD
Cyproheptadine—Headache—Levothyroxine—hypothyroidism	0.00505	0.00735	CcSEcCtD
Cyproheptadine—Headache—Dextrothyroxine—hypothyroidism	0.00505	0.00735	CcSEcCtD
Cyproheptadine—Feeling abnormal—Liotrix—hypothyroidism	0.00489	0.00711	CcSEcCtD
Cyproheptadine—Nausea—Levothyroxine—hypothyroidism	0.00479	0.00697	CcSEcCtD
Cyproheptadine—Nausea—Dextrothyroxine—hypothyroidism	0.00479	0.00697	CcSEcCtD
Cyproheptadine—Urticaria—Liotrix—hypothyroidism	0.00471	0.00685	CcSEcCtD
Cyproheptadine—HTR1A—cardiovascular system—hypothyroidism	0.00454	0.0244	CbGeAlD
Cyproheptadine—Asthenia—Liotrix—hypothyroidism	0.00426	0.00619	CcSEcCtD
Cyproheptadine—SLC6A2—gonad—hypothyroidism	0.00409	0.022	CbGeAlD
Cyproheptadine—Diarrhoea—Liotrix—hypothyroidism	0.00406	0.0059	CcSEcCtD
Cyproheptadine—HTR2B—adrenal gland—hypothyroidism	0.00401	0.0216	CbGeAlD
Cyproheptadine—HTR2B—blood—hypothyroidism	0.00401	0.0216	CbGeAlD
Cyproheptadine—Dizziness—Liotrix—hypothyroidism	0.00392	0.00571	CcSEcCtD
Cyproheptadine—HTR2B—thyroid gland—hypothyroidism	0.00387	0.0208	CbGeAlD
Cyproheptadine—Vomiting—Liotrix—hypothyroidism	0.00377	0.00549	CcSEcCtD
Cyproheptadine—Rash—Liotrix—hypothyroidism	0.00374	0.00544	CcSEcCtD
Cyproheptadine—Dermatitis—Liotrix—hypothyroidism	0.00374	0.00544	CcSEcCtD
Cyproheptadine—Headache—Liotrix—hypothyroidism	0.00372	0.00541	CcSEcCtD
Cyproheptadine—DRD2—pituitary gland—hypothyroidism	0.00363	0.0195	CbGeAlD
Cyproheptadine—HTR1A—adrenal gland—hypothyroidism	0.00359	0.0193	CbGeAlD
Cyproheptadine—SLC6A2—adrenal gland—hypothyroidism	0.00356	0.0192	CbGeAlD
Cyproheptadine—Nausea—Liotrix—hypothyroidism	0.00352	0.00512	CcSEcCtD
Cyproheptadine—CHRM3—thyroid gland—hypothyroidism	0.00348	0.0187	CbGeAlD
Cyproheptadine—CHRM3—female gonad—hypothyroidism	0.00336	0.0181	CbGeAlD
Cyproheptadine—CHRM3—testis—hypothyroidism	0.00298	0.016	CbGeAlD
Cyproheptadine—SLC6A2—testis—hypothyroidism	0.00295	0.0158	CbGeAlD
Cyproheptadine—HTR2A—heart—hypothyroidism	0.00287	0.0154	CbGeAlD
Cyproheptadine—HTR1A—cerebellum—hypothyroidism	0.00274	0.0148	CbGeAlD
Cyproheptadine—HTR2A—cardiovascular system—hypothyroidism	0.00271	0.0146	CbGeAlD
Cyproheptadine—DRD2—testis—hypothyroidism	0.00268	0.0144	CbGeAlD
Cyproheptadine—HRH1—adrenal gland—hypothyroidism	0.00256	0.0138	CbGeAlD
Cyproheptadine—DRD2—cerebellum—hypothyroidism	0.00248	0.0133	CbGeAlD
Cyproheptadine—HTR2A—gonad—hypothyroidism	0.00246	0.0132	CbGeAlD
Cyproheptadine—HTR2A—pituitary gland—hypothyroidism	0.0024	0.0129	CbGeAlD
Cyproheptadine—HRH1—female gonad—hypothyroidism	0.00239	0.0129	CbGeAlD
Cyproheptadine—HTR2A—adrenal gland—hypothyroidism	0.00214	0.0115	CbGeAlD
Cyproheptadine—HTR2A—blood—hypothyroidism	0.00214	0.0115	CbGeAlD
Cyproheptadine—HRH1—testis—hypothyroidism	0.00212	0.0114	CbGeAlD
Cyproheptadine—HTR2A—testis—hypothyroidism	0.00177	0.00952	CbGeAlD
Cyproheptadine—HTR2A—liver—hypothyroidism	0.00167	0.009	CbGeAlD
Cyproheptadine—HTR2A—cerebellum—hypothyroidism	0.00164	0.0088	CbGeAlD
Cyproheptadine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000241	0.00191	CbGpPWpGaD
Cyproheptadine—HTR1A—G alpha (i) signalling events—POMC—hypothyroidism	0.000238	0.00188	CbGpPWpGaD
Cyproheptadine—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000233	0.00184	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—TRH—hypothyroidism	0.000233	0.00184	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—TSHB—hypothyroidism	0.000233	0.00184	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—TSHR—hypothyroidism	0.000233	0.00184	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—TRH—hypothyroidism	0.000232	0.00183	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—TSHB—hypothyroidism	0.000229	0.00181	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR ligand binding—AVP—hypothyroidism	0.000217	0.00171	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR ligand binding—AVP—hypothyroidism	0.000216	0.00171	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—TRH—hypothyroidism	0.000212	0.00167	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—TRH—hypothyroidism	0.000211	0.00167	CbGpPWpGaD
Cyproheptadine—DRD2—G alpha (i) signalling events—POMC—hypothyroidism	0.000209	0.00165	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—TSHB—hypothyroidism	0.000208	0.00164	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—TSHR—hypothyroidism	0.000208	0.00164	CbGpPWpGaD
Cyproheptadine—SLC6A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000207	0.00164	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—TSHB—hypothyroidism	0.000207	0.00164	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—TSHR—hypothyroidism	0.000207	0.00164	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—TRH—hypothyroidism	0.000205	0.00162	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—PIK3C2A—hypothyroidism	0.000204	0.00161	CbGpPWpGaD
Cyproheptadine—CHRM2—G alpha (i) signalling events—POMC—hypothyroidism	0.000202	0.0016	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—TRH—hypothyroidism	0.000201	0.00159	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—TRH—hypothyroidism	0.000201	0.00159	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—TRH—hypothyroidism	0.0002	0.00158	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—TRH—hypothyroidism	0.0002	0.00158	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—TRH—hypothyroidism	0.000198	0.00156	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CLTC—hypothyroidism	0.000196	0.00155	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR ligand binding—POMC—hypothyroidism	0.000195	0.00154	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR ligand binding—AVP—hypothyroidism	0.00019	0.00151	CbGpPWpGaD
Cyproheptadine—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000189	0.0015	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—TSHB—hypothyroidism	0.000189	0.00149	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—TSHR—hypothyroidism	0.000189	0.00149	CbGpPWpGaD
Cyproheptadine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000188	0.00149	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—TSHB—hypothyroidism	0.000188	0.00148	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—TSHR—hypothyroidism	0.000188	0.00148	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR ligand binding—AVP—hypothyroidism	0.000187	0.00148	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR ligand binding—AVP—hypothyroidism	0.000187	0.00148	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR ligand binding—AVP—hypothyroidism	0.000186	0.00147	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—TRH—hypothyroidism	0.000186	0.00147	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR ligand binding—AVP—hypothyroidism	0.000186	0.00147	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR ligand binding—AVP—hypothyroidism	0.000184	0.00145	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—TRH—hypothyroidism	0.000183	0.00145	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—TRH—hypothyroidism	0.000183	0.00144	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—TSHB—hypothyroidism	0.000182	0.00144	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—TSHR—hypothyroidism	0.000182	0.00144	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—TRH—hypothyroidism	0.000182	0.00144	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—TRH—hypothyroidism	0.000181	0.00143	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—TRH—hypothyroidism	0.00018	0.00142	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—TSHB—hypothyroidism	0.00018	0.00142	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—TSHR—hypothyroidism	0.00018	0.00142	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—TSHB—hypothyroidism	0.000179	0.00142	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—TSHR—hypothyroidism	0.000179	0.00142	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—TSHB—hypothyroidism	0.000179	0.00141	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—TSHR—hypothyroidism	0.000179	0.00141	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CLTC—hypothyroidism	0.000178	0.00141	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—TSHB—hypothyroidism	0.000178	0.00141	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—TSHR—hypothyroidism	0.000178	0.00141	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR ligand binding—POMC—hypothyroidism	0.000178	0.0014	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—TSHR—hypothyroidism	0.000176	0.00139	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—TSHB—hypothyroidism	0.000176	0.00139	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—VAV3—hypothyroidism	0.000172	0.00136	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—SLC5A5—hypothyroidism	0.000171	0.00135	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TRH—hypothyroidism	0.000169	0.00134	CbGpPWpGaD
Cyproheptadine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000166	0.00131	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—TSHB—hypothyroidism	0.000166	0.00131	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—TSHR—hypothyroidism	0.000166	0.00131	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—AVP—hypothyroidism	0.000165	0.00131	CbGpPWpGaD
Cyproheptadine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000163	0.00129	CbGpPWpGaD
Cyproheptadine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000163	0.00129	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—TSHR—hypothyroidism	0.000163	0.00129	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—TSHB—hypothyroidism	0.000163	0.00129	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—TSHB—hypothyroidism	0.000163	0.00129	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—TSHR—hypothyroidism	0.000163	0.00129	CbGpPWpGaD
Cyproheptadine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000163	0.00129	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—TSHB—hypothyroidism	0.000162	0.00128	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—TSHR—hypothyroidism	0.000162	0.00128	CbGpPWpGaD
Cyproheptadine—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000162	0.00128	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—TSHB—hypothyroidism	0.000162	0.00128	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—TSHR—hypothyroidism	0.000162	0.00128	CbGpPWpGaD
Cyproheptadine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00016	0.00127	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—TSHB—hypothyroidism	0.00016	0.00127	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—TSHR—hypothyroidism	0.00016	0.00127	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—VAV3—hypothyroidism	0.000157	0.00124	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—VAV3—hypothyroidism	0.000156	0.00123	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TRH—hypothyroidism	0.000154	0.00122	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—AVP—hypothyroidism	0.000151	0.00119	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TSHR—hypothyroidism	0.000151	0.00119	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TSHB—hypothyroidism	0.000151	0.00119	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—AVP—hypothyroidism	0.00015	0.00119	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CLTC—hypothyroidism	0.000145	0.00114	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR ligand binding—POMC—hypothyroidism	0.000144	0.00114	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CLTC—hypothyroidism	0.000144	0.00114	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR ligand binding—POMC—hypothyroidism	0.000143	0.00113	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—VAV3—hypothyroidism	0.000142	0.00113	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TSHB—hypothyroidism	0.000137	0.00109	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TSHR—hypothyroidism	0.000137	0.00109	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—AVP—hypothyroidism	0.000137	0.00108	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—SH2B3—hypothyroidism	0.000134	0.00106	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—VAV3—hypothyroidism	0.000127	0.00101	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CLTC—hypothyroidism	0.000127	0.001	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—VAV3—hypothyroidism	0.000126	0.001	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR ligand binding—POMC—hypothyroidism	0.000126	0.001	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TRH—hypothyroidism	0.000125	0.000989	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CLTC—hypothyroidism	0.000125	0.000989	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CLTC—hypothyroidism	0.000125	0.000987	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TRH—hypothyroidism	0.000124	0.000984	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR ligand binding—POMC—hypothyroidism	0.000124	0.000984	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CLTC—hypothyroidism	0.000124	0.000984	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR ligand binding—POMC—hypothyroidism	0.000124	0.000982	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CLTC—hypothyroidism	0.000124	0.00098	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR ligand binding—POMC—hypothyroidism	0.000124	0.000979	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR ligand binding—POMC—hypothyroidism	0.000123	0.000976	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CLTC—hypothyroidism	0.000123	0.000971	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—SH2B3—hypothyroidism	0.000123	0.000969	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—AVP—hypothyroidism	0.000122	0.000969	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR ligand binding—POMC—hypothyroidism	0.000122	0.000966	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	0.000122	0.000964	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—VAV3—hypothyroidism	0.000115	0.000913	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	0.000115	0.000908	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—TSHB—hypothyroidism	0.000114	0.000903	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	0.000112	0.000883	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TSHB—hypothyroidism	0.000111	0.000882	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TSHR—hypothyroidism	0.000111	0.000882	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—AVP—hypothyroidism	0.000111	0.00088	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TSHB—hypothyroidism	0.000111	0.000877	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TSHR—hypothyroidism	0.000111	0.000877	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—AVP—hypothyroidism	0.000111	0.000875	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—POMC—hypothyroidism	0.00011	0.00087	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	0.00011	0.000869	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TRH—hypothyroidism	0.00011	0.000869	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—VAV3—hypothyroidism	0.00011	0.000867	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—VAV3—hypothyroidism	0.000109	0.000864	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—VAV3—hypothyroidism	0.000109	0.000861	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TRH—hypothyroidism	0.000108	0.000855	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—VAV3—hypothyroidism	0.000108	0.000853	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TRH—hypothyroidism	0.000108	0.000853	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—AVP—hypothyroidism	0.000108	0.000851	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TRH—hypothyroidism	0.000107	0.00085	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TRH—hypothyroidism	0.000107	0.000847	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TRH—hypothyroidism	0.000106	0.000839	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	0.000106	0.000837	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—AVP—hypothyroidism	0.000106	0.000835	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—AVP—hypothyroidism	0.000105	0.000832	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—AVP—hypothyroidism	0.000105	0.00083	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—AVP—hypothyroidism	0.000104	0.000822	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3C2A—hypothyroidism	0.000102	0.000805	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—VAV3—hypothyroidism	0.000101	0.000802	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—POMC—hypothyroidism	0.0001	0.000794	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—POMC—hypothyroidism	9.99e-05	0.00079	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	9.97e-05	0.000789	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PRL—hypothyroidism	9.96e-05	0.000788	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—VAV3—hypothyroidism	9.95e-05	0.000787	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SH2B3—hypothyroidism	9.94e-05	0.000786	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—VAV3—hypothyroidism	9.92e-05	0.000785	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—VAV3—hypothyroidism	9.89e-05	0.000782	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	9.89e-05	0.000782	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—VAV3—hypothyroidism	9.79e-05	0.000774	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TSHB—hypothyroidism	9.79e-05	0.000774	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TSHR—hypothyroidism	9.79e-05	0.000774	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—AVP—hypothyroidism	9.77e-05	0.000772	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TSHB—hypothyroidism	9.63e-05	0.000762	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TSHR—hypothyroidism	9.63e-05	0.000762	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TSHB—hypothyroidism	9.61e-05	0.00076	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TSHR—hypothyroidism	9.61e-05	0.00076	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—AVP—hypothyroidism	9.61e-05	0.00076	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—AVP—hypothyroidism	9.59e-05	0.000758	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TSHB—hypothyroidism	9.58e-05	0.000758	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TSHR—hypothyroidism	9.58e-05	0.000758	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—AVP—hypothyroidism	9.56e-05	0.000756	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TSHB—hypothyroidism	9.55e-05	0.000755	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TSHR—hypothyroidism	9.55e-05	0.000755	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—AVP—hypothyroidism	9.53e-05	0.000754	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TSHB—hypothyroidism	9.46e-05	0.000748	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TSHR—hypothyroidism	9.46e-05	0.000748	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—AVP—hypothyroidism	9.43e-05	0.000746	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—VAV3—hypothyroidism	9.21e-05	0.000729	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—POMC—hypothyroidism	9.11e-05	0.000721	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PRL—hypothyroidism	9.09e-05	0.000719	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—POMC—hypothyroidism	8.95e-05	0.000708	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AVP—hypothyroidism	8.88e-05	0.000702	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SH2B3—hypothyroidism	8.72e-05	0.00069	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	8.58e-05	0.000679	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SH2B3—hypothyroidism	8.57e-05	0.000677	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—SLC5A5—hypothyroidism	8.55e-05	0.000676	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SH2B3—hypothyroidism	8.54e-05	0.000675	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SH2B3—hypothyroidism	8.51e-05	0.000673	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SH2B3—hypothyroidism	8.43e-05	0.000667	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—VAV3—hypothyroidism	8.41e-05	0.000665	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—POMC—hypothyroidism	8.14e-05	0.000644	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AVP—hypothyroidism	8.1e-05	0.000641	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	8.1e-05	0.00064	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—POMC—hypothyroidism	7.39e-05	0.000585	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PRL—hypothyroidism	7.37e-05	0.000583	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—POMC—hypothyroidism	7.35e-05	0.000582	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PRL—hypothyroidism	7.33e-05	0.00058	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—POMC—hypothyroidism	7.15e-05	0.000565	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	7.03e-05	0.000556	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—POMC—hypothyroidism	7.02e-05	0.000555	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—POMC—hypothyroidism	6.99e-05	0.000553	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—POMC—hypothyroidism	6.97e-05	0.000551	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—POMC—hypothyroidism	6.9e-05	0.000546	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VAV3—hypothyroidism	6.82e-05	0.000539	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VAV3—hypothyroidism	6.78e-05	0.000537	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AVP—hypothyroidism	6.57e-05	0.00052	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AVP—hypothyroidism	6.54e-05	0.000517	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—POMC—hypothyroidism	6.49e-05	0.000513	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PRL—hypothyroidism	6.47e-05	0.000512	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—POMC—hypothyroidism	6.39e-05	0.000505	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—POMC—hypothyroidism	6.37e-05	0.000504	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PRL—hypothyroidism	6.37e-05	0.000504	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PRL—hypothyroidism	6.35e-05	0.000503	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—POMC—hypothyroidism	6.35e-05	0.000502	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PRL—hypothyroidism	6.33e-05	0.000501	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—POMC—hypothyroidism	6.33e-05	0.000501	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PRL—hypothyroidism	6.31e-05	0.000499	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—POMC—hypothyroidism	6.27e-05	0.000496	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PRL—hypothyroidism	6.25e-05	0.000495	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VAV3—hypothyroidism	5.99e-05	0.000474	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—POMC—hypothyroidism	5.9e-05	0.000467	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VAV3—hypothyroidism	5.89e-05	0.000466	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VAV3—hypothyroidism	5.88e-05	0.000465	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VAV3—hypothyroidism	5.86e-05	0.000463	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VAV3—hypothyroidism	5.84e-05	0.000462	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VAV3—hypothyroidism	5.78e-05	0.000458	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AVP—hypothyroidism	5.77e-05	0.000456	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AVP—hypothyroidism	5.68e-05	0.000449	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IGF1—hypothyroidism	5.67e-05	0.000449	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AVP—hypothyroidism	5.66e-05	0.000448	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AVP—hypothyroidism	5.65e-05	0.000447	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AVP—hypothyroidism	5.63e-05	0.000445	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AVP—hypothyroidism	5.57e-05	0.000441	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—POMC—hypothyroidism	5.38e-05	0.000426	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IGF1—hypothyroidism	5.18e-05	0.00041	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—POMC—hypothyroidism	4.47e-05	0.000354	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—POMC—hypothyroidism	4.37e-05	0.000345	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—POMC—hypothyroidism	4.34e-05	0.000344	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IGF1—hypothyroidism	4.2e-05	0.000332	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IGF1—hypothyroidism	4.18e-05	0.00033	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—POMC—hypothyroidism	3.83e-05	0.000303	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—POMC—hypothyroidism	3.77e-05	0.000298	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—POMC—hypothyroidism	3.76e-05	0.000298	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—POMC—hypothyroidism	3.75e-05	0.000297	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—POMC—hypothyroidism	3.74e-05	0.000296	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—POMC—hypothyroidism	3.7e-05	0.000293	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IGF1—hypothyroidism	3.69e-05	0.000292	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IGF1—hypothyroidism	3.63e-05	0.000287	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IGF1—hypothyroidism	3.62e-05	0.000286	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IGF1—hypothyroidism	3.61e-05	0.000285	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IGF1—hypothyroidism	3.6e-05	0.000285	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IGF1—hypothyroidism	3.56e-05	0.000282	CbGpPWpGaD
